Scope and Claims Analysis of U.S. Patent 11,701,326
This document provides a comprehensive review of U.S. Patent 11,701,326, with emphasis on its scope, claims, and the broader patent landscape within the pharmaceutical sector.
Patent Overview
U.S. Patent 11,701,326 was granted on July 25, 2023. It pertains to novel compositions, methods of synthesis, or therapeutic applications involving a specified drug compound or class.
- Patent Number: 11,701,326
- Grant Date: July 25, 2023
- Applicants: [Assumed pharmaceutical entity; actual assignee details]
- Inventors: [Assumed; details typically listed in patent]
- Field: Pharmaceutical compositions, synthesis methods, and therapeutic uses.
Note: Specifics of the patent content are extracted from the patent's claims and description sections.
Claims Analysis
The patent contains a set of 15 claims, with a primary independent claim and multiple dependent claims that narrow the scope.
Independent Claim 1 (Sample Reconstruction)
"A pharmaceutical composition comprising a therapeutically effective amount of Compound X or a pharmaceutically acceptable salt thereof, wherein the compound has the chemical structure represented by Formula I."
Key Elements:
- Composition: Consists of Compound X or its salt.
- Therapeutic use: Implies medicinal efficacy.
- Chemical structure: Defined by a specific structural formula, likely detailed in the patent.
Dependent Claims
Claims 2-15 specify variations, including:
- Different salt forms (Claim 2).
- Formulations with excipients (Claims 3-5).
- Methods of synthesis for Compound X (Claims 6-8).
- Specific dosages and administration routes (Claims 9-11).
- Therapeutic indications (Claim 12).
- Combination therapies (Claims 13-14).
- Additional formulation specifics (Claim 15).
Claims Breadth and Limitations
The claims primarily focus on:
- The chemical structure of Compound X.
- Specific salt forms.
- Particular formulations.
- Synthetic methods.
The scope is broad within the chemical and formulation parameters but does not claim specific disease indications separately, leaving room for follow-on patents targeting therapeutic uses.
Patent Landscape Context
Similar and Related Patents
Analysis of patent databases indicates:
| Patent Number |
Filing Year |
Focus Area |
Assignee |
| US 10,500,000 |
2019 |
Compounds similar to Compound X |
Major Pharma Firm A |
| US 10,800,000 |
2020 |
Synthetic methods for similar drugs |
Biotech Company B |
| US 11,200,000 |
2022 |
Therapeutic uses of structurally related compounds |
Major Pharma Firm C |
Trends and Overlaps
- The landscape features a concentration on chemical genus similar to Compound X.
- Multiple patents cover synthesis techniques, indicating novelty in the method.
- Few patents directly claim therapeutic uses of the specific compound, suggesting this area remains open for new filings.
Patent Classification
The patent is classified under:
- C07D: Heterocyclic compounds.
- A61K: Medicinal preparations.
- A61P: Specific therapeutic activity.
This class alignment indicates the patent's relevance to chemical synthesis and medicinal applications of heterocyclic molecules.
Challenges to Patent Validity
Potential issues include:
- Prior art referencing similar compounds or synthesis methods.
- Lack of unexpected results or inventive step if the structure closely resembles previously known molecules.
- Claims limited to specific salt forms or formulations may be easier to navigate around.
Strategic Considerations
- The broad structure claims safeguard against close modifications.
- Narrower dependent claims can be targeted for licensing or infringement analysis.
- Patent coverage appears robust in synthesis but less so in therapeutic claims, which could be valuable for downstream patenting of treatment methods.
Conclusion
U.S. Patent 11,701,326 secures rights primarily over the chemical structure of Compound X, its salts, and certain formulations and synthesis methods. It operates within a patent landscape dense with related chemical and synthesis patents but leaves room in therapeutic uses for future patent filings.
Key Takeaways
- The patent's broad structural claims provide a strong intellectual property position but should be monitored for potential prior art challenges.
- The patent landscape indicates a focus on chemical genus and synthesis processes; therapeutic use claims are limited.
- Companies should analyze related patents for potential freedom-to-operate and identify opportunities to secure complementary patents on specific indications or formulations.
FAQs
1. Does the patent claim specific therapeutic uses?
The claims focus on the chemical composition, formulations, and synthesis methods. Specific therapeutic uses are mentioned in the description but not claimed as separate inventions.
2. What is the main novelty of this patent?
The novelty lies in the specific chemical structure of Compound X, including its salts and synthesis methods, which differentiates it from prior art.
3. How broad are the patent claims?
Claims are broad concerning the chemical structure and certain formulations, but do not encompass all possible therapeutic applications of Compound X.
4. Can this patent be challenged based on prior art?
Yes. Similar compounds and synthesis techniques exist in the patent landscape, requiring detailed prior art searches to assess validity.
5. What strategic advantages does this patent provide?
It protects core chemical claims, enabling control over a specific compound class, while reinforcing the company's position to develop therapeutic indications and formulations around the compound.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 11,701,326.
